Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy (Q43102710)
Jump to navigation
Jump to search
scientific article published on 18 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy |
scientific article published on 18 May 2009 |
Statements
1 reference
Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy (English)
1 reference
1 reference
Jean-François Delfraissy
1 reference
Christine Rouzioux
1 reference
Anne-Marie Taburet
1 reference
Constance Delaugerre
1 reference
Philippe Ngo Van
1 reference
Isabelle Cohen-Codar
1 reference
François Raffi
1 reference
Marie Laure Chaix
1 reference
Jade Ghosn
1 reference
MONARK Study Group
1 reference
Pierre Dellamonica
1 reference
H Jaeger
1 reference
D Shürmann
1 reference
Michael Norton
1 reference
18 May 2009
1 reference
1 reference
53
1 reference
2934-2939
1 reference
Identifiers
1 reference
1 reference
1 reference